Vision UK 2013 speakers announced

Article

The Vision UK 2013 conference, on the 11 June, has confirmed several key speakers, announced the UK Vision Strategy.

The Vision UK 2013 conference, on the 11 June, has confirmed several key speakers, announced the UK Vision Strategy.

The speakers include UK experts in eye health, social care and sight loss, as well as directors of leading sight loss charities. Notable speakers will be Dr Clare Gerada, Chair for the Royal College of General Practitioners, Lesley-Anne Alexander CBE, the Chief Executive RNIB and Chair of UK Vision Strategy and Parul Desai from Moorfields Eye Hospital.

Anna Lightstone, UK Vision Strategy Programme Director and VISION 2020 UK Interim Chief Operations Officer, stated, "Vision UK 2013 is about 'progress through partnership'– working with our partners and supporters to make real changes with eye care and sight loss across the UK. Our partners have been central to the development of the refreshed Strategy and now we would like their help in turning it into a reality over the next five years."

The conference is expected to play host to over 400 delegates from across the UK health, social care and voluntary sectors and will launch the refreshed UK Vision Strategy for 2013-2018.

Please visit the Vision 2020 UK website for more details.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.